BTIG Research has reaffirmed their buy rating on Haemonetics Corporation's stock with a target price of $88.00 per share, according to Benzinga. Other brokerage firms have also reviewed and revised th...

Ethic Inc. has increased its stake in Zimmer Biomet Holdings by purchasing an additional 7,833 shares during the third quarter, bringing their total holdings to 14,041 shares....